Strategic Financial Concepts LLC Purchases New Shares in Haleon plc (NYSE:HLN)

Strategic Financial Concepts LLC acquired a new position in Haleon plc (NYSE:HLN) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 88,757 shares of the company’s stock, valued at approximately $847,000.

Other large investors have also recently modified their holdings of the company. Bleakley Financial Group LLC lifted its holdings in Haleon by 24.6% in the fourth quarter. Bleakley Financial Group LLC now owns 14,784 shares of the company’s stock worth $141,000 after buying an additional 2,921 shares during the period. Mather Group LLC. raised its position in shares of Haleon by 177.4% in the 4th quarter. Mather Group LLC. now owns 5,623 shares of the company’s stock worth $54,000 after acquiring an additional 3,596 shares in the last quarter. Optas LLC purchased a new position in shares of Haleon in the 4th quarter valued at approximately $173,000. Resonant Capital Advisors LLC boosted its position in shares of Haleon by 8.6% during the fourth quarter. Resonant Capital Advisors LLC now owns 20,738 shares of the company’s stock valued at $198,000 after purchasing an additional 1,641 shares in the last quarter. Finally, Catalina Capital Group LLC bought a new stake in shares of Haleon during the fourth quarter valued at approximately $245,000. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Trading Up 1.7 %

Haleon stock opened at $9.85 on Wednesday. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a market capitalization of $44.57 billion, a price-to-earnings ratio of 28.96, a price-to-earnings-growth ratio of 2.70 and a beta of 0.28. The business’s fifty day simple moving average is $9.53 and its two-hundred day simple moving average is $9.79. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.